Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)00:53

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)

1.9K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.9K
Legal Guidelines for Documentation01:06

Legal Guidelines for Documentation

1.3K
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
1.3K
Global Regulatory Systems01:28

Global Regulatory Systems

44
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
44
[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement01:21

[3,3] Sigmatropic Rearrangement of 1,5-Dienes: Cope Rearrangement

2.8K
The Cope rearrangement is classified as a [3,3] sigmatropic shift in 1,5-dienes, leading to a more stable, isomeric 1,5-diene. The reaction involves a concerted movement of six electrons, four from two π bonds and two from a σ bond, via an energetically favorable chair-like transition state.
2.8K
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

833
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
833
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.1K
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands.

Infectious diseases and therapy·2026
Same author

Cost per event avoided: adopt or avoid?

Journal of medical economics·2026
Same author

Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in Portugal.

PharmacoEconomics - open·2026
Same author

Where Are the Gaps in Diabetes Care? An Evidence Gap Mapping of the Diabetes Patient Journey in Indonesia.

Tropical medicine & international health : TM & IH·2026
Same author

Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers.

Journal of comparative effectiveness research·2025
Same author

National outpatient antibiotic prescriptions in Cyprus, 2020-2022.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same journal

The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Comparative landscape of artificial intelligence-assisted systematic literature reviews.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Real-world direct medical costs and resource utilization of immune checkpoint inhibitors in advanced NSCLC with COPD: a multicenter cost-consequence analysis from Iraq.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

TENS in chronic pain management: a 11-year nationwide analysis using the French National Health Data System.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Economic burden of breast cancer in Cyprus from a societal perspective.

Expert review of pharmacoeconomics & outcomes research·2026
See all related articles

Related Experiment Video

Updated: Jul 22, 2025

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.6K

Implementing a Managed Entry Agreement Framework in Cyprus.

Olga Pitsillidou1,2, Panagiotis Petrou2,3, M J Postma1,4

  • 1Department of Health Sciences, Unit of Global Health, University of Groningen, Groningen, The Netherlands.

Expert Review of Pharmacoeconomics & Outcomes Research
|July 23, 2023
PubMed
Summary
This summary is machine-generated.

Cyprus is exploring Managed Entry Agreements (MEA) for innovative pharmaceuticals. Despite its small market, the country can implement substantial MEA programs, requiring a defined operational framework for success.

Keywords:
CyprusHTAMEA implementationcost-effectivenesshealth system transitioninnovative pharmaceuticalssmall countryvalue-based pricing

More Related Videos

Synthesis of Programmable Main-chain Liquid-crystalline Elastomers Using a Two-stage Thiol-acrylate Reaction
11:17

Synthesis of Programmable Main-chain Liquid-crystalline Elastomers Using a Two-stage Thiol-acrylate Reaction

Published on: January 19, 2016

21.9K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.6K

Related Experiment Videos

Last Updated: Jul 22, 2025

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

2.6K
Synthesis of Programmable Main-chain Liquid-crystalline Elastomers Using a Two-stage Thiol-acrylate Reaction
11:17

Synthesis of Programmable Main-chain Liquid-crystalline Elastomers Using a Two-stage Thiol-acrylate Reaction

Published on: January 19, 2016

21.9K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.6K

Area of Science:

  • Health policy
  • Pharmaceutical economics
  • Healthcare management

Background:

  • Cyprus's recent National Health System (NHS) reforms introduced Managed Entry Agreements (MEA) for innovative pharmaceuticals.
  • Small countries face unique challenges in adopting and reimbursing new medical technologies.

Purpose of the Study:

  • To explore current practices in Cyprus for introducing and reimbursing innovative drugs via MEA.
  • To assess the operational context of MEA implementation in Cyprus.
  • To identify barriers and suggest approaches for knowledge gaps in small country MEA contexts.

Main Methods:

  • Utilized narrative synthesis and health policy analysis.
  • Examined preliminary results from Cyprus's MEA program.
  • Reviewed resources related to healthcare policy and reimbursement.

Main Results:

  • Cyprus, despite being a small market, demonstrates potential for substantial Managed Entry Agreement programs.
  • An operational framework is needed, defining parameters, scope, and value for MEA effectiveness.
  • Budget transfers within a unified market could mitigate the impact of new drug introductions.

Conclusions:

  • Cyprus's MEA implementation serves as a valuable case study for innovative reimbursement strategies.
  • Streamlining innovation reimbursement in Cyprus can enhance collective MEA experience.
  • Developing a clear operational framework is crucial for successful MEA implementation in similar contexts.